Skip to main content
Shanghai Microport Endovascular Medtech(Group) Co.,Ltd. logo

Shanghai Microport Endovascular Medtech(Group) Co.,Ltd. — Investor Relations & Filings

Ticker · 688016 ISIN · CNE1000042Q0 Shanghai Stock Exchange Manufacturing
Filings indexed 810 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688016

About Shanghai Microport Endovascular Medtech(Group) Co.,Ltd.

https://www.endovastec.com/en/

Shanghai Microport Endovascular Medtech (Group) Co., Ltd., known as Endovastec, specializes in the research, development, manufacturing, and commercialization of interventional medical devices for the treatment of aortic and peripheral vascular diseases. The company’s product portfolio includes a comprehensive range of thoracic and abdominal aortic stent grafts, such as the Castor Branched Aortic Stent-Graft System, the Hercules Thoracic Stent-Graft System, and the Minos Abdominal Aortic Stent-Graft System. Additionally, it provides solutions for peripheral vascular interventions, including drug-coated balloons and stent systems. Endovastec focuses on providing minimally invasive endovascular treatment solutions to improve clinical outcomes for patients globally, leveraging advanced engineering and clinical research to address complex vascular pathologies.

Recent filings

Filing Released Lang Actions
心脉医疗:北京市嘉源律师事务所关于上海微创心脉医疗科技(集团)股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 90% confidence The document is a legal opinion letter from a law firm regarding the company’s 2025 Annual General Meeting, confirming the convening procedures, attendance, and voting results under PRC corporate and securities law. It is not the AGM materials themselves (AGM-R) nor a proxy solicitation statement (PSI) but rather a compliance/legal opinion filing. This falls under the fallback category for regulatory filings and compliance documents.
2026-05-14 Chinese
心脉医疗:关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai MicroPort CardioFlow Medtech Corporation about a change in accounting policy due to new guidelines issued by the Ministry of Finance of China regarding financial instruments and standard warehouse receipt transactions. It explains the reason for the change, the main content of the change, the effective date, and the impact on the company. The document is relatively short (1219 characters) and does not contain financial statements or detailed financial data. It is a regulatory announcement about accounting policy changes rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-30 Chinese
心脉医疗:董事会关于独立董事独立性自查情况的专项报告
Governance Information Classification · 95% confidence The document is a special report on the independence of the company's independent directors, referencing regulatory requirements from the China Securities Regulatory Commission and Shanghai Stock Exchange rules. It assesses the independence of specific directors and confirms compliance with relevant independence standards. The document is short (466 characters) and focuses on governance and regulatory compliance related to board members' independence. It does not contain financial data, audit results, or voting results. It fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2026-03-30 Chinese
立信会计师事务所(特殊普通合伙)关于上海微创心脉医疗科技(集团)股份有限公司2025年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled “审计报告及财务报表” and contains an independent auditor’s report with audit opinion, key audit matters, auditor responsibilities, followed by detailed consolidated and parent company financial statements and notes for the year ended December 31, 2025. This is a standalone audit report and financials, not an annual report, earnings release, or other announcement. It corresponds to the Audit Report / Information category (AR).
2026-03-30 Chinese
中国国际金融股份有限公司关于上海微创心脉医疗科技(集团)股份有限公司2025年度日常关联交易确认的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a financial institution (China International Capital Corporation Limited) acting as a sponsor, providing an audit opinion on the confirmation of daily related-party transactions for the fiscal year 2025 of Shanghai MicroPort Heartbeat Medical Technology (Group) Co., Ltd. It includes extensive information on the nature, approval process, amounts, related parties, and compliance with regulations regarding these related-party transactions. The document is not a full annual report or interim financial report but a specific audit or verification report on related-party transactions. It does not contain general financial statements or earnings data but focuses on compliance and confirmation of related-party transactions for the year 2025. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related document concerning accounting and regulatory compliance matters, not a full annual report or earnings release.
2026-03-30 Chinese
心脉医疗:关于2025年度会计师事务所的履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm for the year 2025. It references relevant laws and regulations governing accounting firms and audit practices. The content focuses on the auditor's background, business scale, and audit services provided. It does not contain full financial statements or comprehensive company financial performance data. The document is an audit-related report assessing the auditor's performance rather than a full annual report or standalone audit opinion. Therefore, it fits best under Audit Report / Information (AR). The document length is short but contains substantive audit-related information, not merely an announcement or certification.
2026-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.